FOXO4-DRI
Also known as: FOXO4-D-Retro-Inverso · Proxofim
A senolytic peptide that selectively forces zombie (senescent) cells to self-destruct, reducing systemic inflammation and reversing aging markers.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~2–6 hours
Varies (research protocols)
Subcutaneous injection
Mechanism of Action
Disrupts the FOXO4-p53 interaction that keeps senescent cells alive, forcing them into apoptosis while leaving healthy cells unaffected.
Key Research Areas
Frequently Asked Questions
What is FOXO4-DRI?▾
How does FOXO4-DRI work?▾
What is the recommended dosage for FOXO4-DRI?▾
What is the half-life of FOXO4-DRI?▾
Is FOXO4-DRI FDA approved?▾
Research Disclaimer
The information provided about FOXO4-DRI is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.